Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.

Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.
复制标题

DOI:
10.4049/jimmunol.0803052
复制
发表时间:
2009-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Mauri C
Mauri C
中科院分区:
其他
文献类型:
--
作者:
Blair PA;Chavez-Rueda KA;Evans JG;Shlomchik MJ;Eddaoudi A;Isenberg DA;Ehrenstein MR;Mauri C

文献摘要

参考文献

被引文献

相似文献

我们之前报道过il - 10+调节性B细胞,已知在控制自身免疫和炎症性疾病中起重要作用,包含在过渡-2未成熟(T2) B细胞池(T2Bregs)中。促进其富集或增强其抑制活性的治疗策略是非常有吸引力的。在这里,我们报告了激动性抗cd40特异性靶向T2 B细胞,并在短期体外培养中丰富B regs。虽然从狼疮小鼠中分离的未经处理的T2 B细胞的转移不能给患病小鼠提供保护,但体外抗cd40生成的T2 B细胞(T2样bregs)的转移通过il -10依赖机制显着改善肾脏疾病和生存。T2-like-Bregs易在脾内积聚,抑制Th1应答,诱导IL-10+CD4+T细胞分化,并向CD4+T细胞传递调控作用。此外,体内给药激动性抗cd40,目前正在试验治疗癌症,停止和逆转已建立狼疮。综上所述,我们的结果提出了一种新的细胞方法来改善实验性狼疮。
We have previously reported that IL10+ regulatory B cells, known to play an important role in controlling autoimmunity and inflammatory disorders, are contained within the Transitional-2 immature (T2) B cell pool (T2Bregs). Therapeutic strategies facilitating their enrichment or enhancing their suppressive activity are highly attractive. Here we report that agonistic anti-CD40 specifically targets T2 B cells and enriches B regs upon short term in vitro culture. Whilst transfer of unmanipulated T2 B cells, isolated from mice with established lupus, failed to confer protection to diseased mice, transfer of in vitro anti-CD40-generated T2 B cells (T2-like-Bregs) significantly improved renal disease and survival by an IL-10-dependent mechanism. T2-like-Bregs readily accumulated in the spleen after transfer, suppressed Th1 responses, induced the differentiation of IL-10+CD4+T cells and conveyed regulatory effect to CD4+T cells. In addition, in vivo administration of agonistic anti-CD40, currently on trial for the treatment of cancer, halted and reversed established lupus. Taken together our results suggest a novel cellular approach for the amelioration of experimental lupus.
脾脏中的B细胞发育发生在离散的步骤中,并取决于B细胞受体衍生的信号的质量。
DOI: 10.1084/jem.190.1.75
发表时间: 1999-07-05
影响因子: 15.3
作者:
Loder, F;Mutschler, B;Ray, R J;Paige, C J;Sideras, P;Torres, R;Lamers, M C;Carsetti, R
通讯作者: Carsetti, R
DOI: 10.1016/s1074-7613(02)00274-1
发表时间: 2002-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Mizoguchi, A;Mizoguchi, E;Bhan, AK
通讯作者: Bhan, AK
DOI: 10.1093/rheumatology/kel148
发表时间: 2007-01-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Leandro, M. J.;Cooper, N.;Edwards, J. C. W.
通讯作者: Edwards, J. C. W.
DOI: 10.1038/76251
发表时间: 2000-06-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Mauri, C;Mars, LT;Londei, M
通讯作者: Londei, M
DOI: 10.1172/jci32405
发表时间: 2007-12-01
影响因子: 15.9
作者:
Hu, Chang-Yun;Rodriguez-Pinto, Daniel;Wen, Li
通讯作者: Wen, Li